Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

UPDATE 2-European stocks mark longest weekly winning streak since November 2019

Published 04/09/2021, 04:58 PM
Updated 04/10/2021, 12:10 AM
© Reuters.

(For a Reuters live blog on U.S., UK and European stock
markets, click LIVE/ or type LIVE/ in a news window)
* Markets flat on Friday after record Wall Street rally
* UK markets outperform this week
* TUI slides on bond offering plan

(Adds comments, updates prices throughout)
By Sruthi Shankar and Shreyashi Sanyal
April 9 (Reuters) - European stocks were subdued on Friday,
but marked their longest weekly winning streak since November
2019 as hopes of a rapid recovery in economic growth offset
doubts over the euro zone's COVID-19 vaccination programme.
The pan-European STOXX 600 index .STOXX was up 0.1% after
hitting an all-time high at the open, while the UK's blue-chip
FTSE 100 .FTSE slipped 0.4%.
Global sentiment was underpinned by the U.S. Federal
Reserve's pledge to keep its super-easy policy in place even as
data showed the world's largest economy kicking into higher
gear. London equities have outperformed this week, with the
domestically focused FTSE mid-cap index .FTMC notching a
record high as Britain gradually emerges from a strict winter
coronavirus lockdown.
"While the UK and US have done relatively well on the
vaccination roll-out, continental Europe has lagged," said
Dhaval Joshi, chief strategist at BCA Research.
"But they will sort it out later this year. You'll see an
early rebound in UK and US economies from Q2 onwards. In
continental Europe, it will be later this year rather than Q2."
European stocks hit a series of all-time highs this week,
despite setbacks on the vaccination front after European
regulators found a potential link between AstraZeneca (NASDAQ:AZN)'s COVID-19
vaccine and reports of rare brain blood clots.
"The year has been without a major correction so far, and
with equity inflows continuing to hit new multi-year highs the
sense of 'irrational exuberance' is building once again," said
Chris Beauchamp, chief market analyst at IG.
"Some measure of caution would seem to be the prudent
approach until a more comprehensive conclusion can be drawn."
Investors will shift their focus to the U.S. earnings season
next week, with profits at S&P 500 companies expected to jump
25% in the first quarter, according to Refinitiv IBES estimate.
Airbus AIR.PA rose 0.3% after the French planemaker
reported slightly higher deliveries in the first quarter.
Holiday company TUI TUIT.L fell 2.1% after it said it was
raising 350 million euros ($416.33 million) through an issuance
of convertible bonds to bolster its finances and repay debt.
British American Tobacco BATS.L dropped 2.5%, among the
biggest drags on STOXX 600, after J.P. Morgan downgraded the
stock to "neutral".

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.